You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 1, January 8, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Comments, Opinions, and Brief Case Reports
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Systematic Reviews Neglect Safety Issues

Arch Intern Med. 2001;161:125-126.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The concept of evidence-based medicine is as simple as it is compelling and has indisputably had a major influence on modern therapeutics. Evidence-based medicine aims to objectively evaluate all medical interventions with a view of translating this knowledge into routine medical practice and thus enhancing patient care. One of its most powerful tools to achieve this aim is the systematic review (SR).1 Systematic reviews, including meta-analyses, aim at impartially assessing the evidence for a given treatment and usually focus on efficacy or effectiveness. Yet safety data are equally important for evidence-based decisions about the value (or otherwise) of therapeutic interventions.

To determine to what extent safety issues have been the subject of SRs, the literature was searched using MEDLINE (1966 to November 1999). The search terms were "systematic review," "meta-analysis," "efficacy," "effectiveness," "safety," "adverse effects," "adverse reactions," and derivatives of these terms. Identified articles were categorized according to the time . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Safety Reporting in Randomized Trials of Mental Health Interventions
Papanikolaou et al.
Am. J. Psychiatry 2004;161:1692-1697.
ABSTRACT | FULL TEXT  

Neutropenia due to clopidogrel in a patient with end-stage renal disease
Akcay et al.
The Annals of Pharmacotherapy 2004;38:1538-1539.
FULL TEXT  

Clopidogrel-Associated Leukopenia
McCarthy and Kockler
The Annals of Pharmacotherapy 2003;37:216-219.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.